Atossa Therapeutics (ATOS) Tax Rate (2020 - 2025)
Atossa Therapeutics' (ATOS) quarterly Tax Rate came in at 66.76% in Q4 2025, down 1762.0% year-over-year from 4.02% in Q4 2024, and down 20.88% quarter-over-quarter from 84.39% in Q4 2024.
Analysis
Atossa Therapeutics (ATOS) Tax Rate (2020 - 2025) Analysis & Trends
Atossa Therapeutics (ATOS) has reported Tax Rate for 6 consecutive years, with 66.76% the latest figure, recorded in Q4 2025.
- On a quarterly basis, Tax Rate fell 1762.0% year-over-year to 66.76% in Q4 2025; TTM through Jun 2026 was 19.36%, a 71.0% increase from a year earlier, with the FY2025 full-year figure at 21.0%, changed 0.0% from the prior year.
- Tax Rate was 66.76% for Q4 2025 at Atossa Therapeutics, down from 84.39% in the prior quarter.
- Over five years, Tax Rate peaked at 89.55% in Q4 2021 and troughed at 66.76% in Q4 2025.
- A 5-year average of 79.56% and a median of 81.51% in 2023 frame the typical range for Tax Rate.
- Across the five-year window, Tax Rate jumped 3952 bps in 2021 and plunged 1762 bps in 2025, its largest moves.
- Over 5 years, Tax Rate stood at 89.55% in 2021, then fell by 16 bps to 75.58% in 2022, then grew by 8 bps to 81.51% in 2023, then advanced by 4 bps to 84.39% in 2024, then dropped by 21 bps to 66.76% in 2025.
- The last three Tax Rate figures came in at 66.76% (Q4 2025), 84.39% (Q4 2024), and 81.51% (Q4 2023), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Tax Rate (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 663.08 Bn | 642.33 Bn | 17.26 Bn | 17.98% |
| 2 | AbbVie | 453.04 Bn | 446.51 Bn | 12.70 Bn | 15.47% |
| 3 | Merck | 370.87 Bn | 363.78 Bn | 12.21 Bn | -95.75% |
| 4 | Novartis Ag | 305.29 Bn | 298.00 Bn | 11.24 Bn | -23.71% |
| 5 | Pfizer | 162.10 Bn | 150.70 Bn | 10.94 Bn | 62.33% |
| 6 | Sanofi | 53.95 Bn | 46.98 Bn | 10.79 Bn | -31.96% |
| 7 | Revolution Medicines | 45.00 Bn | 45.00 Bn | - | - |
| 8 | Incyte | 25.47 Bn | 20.94 Bn | 1.57 Bn | 22.08% |
| 9 | United Therapeutics | 20.81 Bn | 18.15 Bn | 683.80 Mn | 10.65% |
| 10 | Atossa Therapeutics | 25.15 Mn | 25.15 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 66.76% |
| Dec 31, 2024 | 84.39% |
| Dec 31, 2023 | 81.51% |
| Dec 31, 2022 | 75.58% |
| Dec 31, 2021 | 89.55% |
| Dec 31, 2020 | 50.03% |